Results 201 to 210 of about 76,053 (241)
Some of the next articles are maybe not open access.

Capecitabine

Drugs, 1999
Capecitabine is an orally administered fluoropyrimidine carbamate used for the treatment of paclitaxel- or anthracycline-refractory breast cancer. Capecitabine is metabolised via a 3-step process to the active agent fluorouracil. The final step of this process occurs preferentially in malignant tissue.
M, Dooley, K L, Goa
openaire   +2 more sources

Capecitabine: A review

Clinical Therapeutics, 2005
Fluorouracil (FU) is an antimetabolite with activity against numerous types of neoplasms, including those of the breast, esophagus, larynx, and gastrointestinal and genitourinary tracts. Systemic toxicity, including neutropenia, stomatitis, and diarrhea, often occur due to cytotoxic nonselectivity.
Christine M, Walko, Celeste, Lindley
openaire   +2 more sources

Capecitabine

Investigational New Drugs, 2000
Drug development has undergone rapid shifts in methodology and the use of rationally derived agents which either target specific tissues or molecules such as receptors or enzymatic sites. Capecitabine is a rationally derived prodrug of 5-fluorouracil which is based upon the known high concentration of the enzyme thymidine phosphorylase in many human ...
openaire   +2 more sources

Capecitabine

Reactions Weekly, 2022
openaire   +2 more sources

Capecitabine

Reactions Weekly, 2023
openaire   +2 more sources

Capecitabine leukoencephalopathy

Practical Neurology, 2019
Zeid, Yasiry   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy